Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Pfizer has selected Havas’ Arnold to handle creative for the launch of its migraine drug Relpax this year, the client said.
“Based on the change in thinking and strategy, we decided that Arnold was the best agency for this account,” said Pfizer representative Michal Fishman.
The win comes after a review in which the New York client began soliciting ideas in October from Arnold, WPP Group’s Berlin Cameron/Red Cell and the incumbent, Publicis Groupe’s Publicis, all New York [Adweek, Nov.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in